CO - Global Cord Blood Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5701.35M
Enterprise Value 3701.35M
Trailing P/E 19.69
Forward P/E 19.95
PEG Ratio (5 yr expected) 10.72
Price/Sales (ttm)N/A
Price/Book (mrq)1.41
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.31
52-Week Change 3-37.65%
S&P500 52-Week Change 37.40%
52 Week High 39.60
52 Week Low 34.82
50-Day Moving Average 36.32
200-Day Moving Average 36.54

Share Statistics

Avg Vol (3 month) 351.32k
Avg Vol (10 day) 3106.97k
Shares Outstanding 5121.55M
Float 21.54M
% Held by Insiders 170.52%
% Held by Institutions 118.09%
Shares Short (Jun 14, 2019) 4400.99k
Short Ratio (Jun 14, 2019) 46.41
Short % of Float (Jun 14, 2019) 41.55%
Short % of Shares Outstanding (Jun 14, 2019) 40.33%
Shares Short (prior month May 15, 2019) 4463.6k

Dividends & Splits

Forward Annual Dividend Rate 40.08
Forward Annual Dividend Yield 41.38%
Trailing Annual Dividend Rate 30.08
Trailing Annual Dividend Yield 31.31%
5 Year Average Dividend Yield 4N/A
Payout Ratio 422.72%
Dividend Date 3Aug 24, 2018
Ex-Dividend Date 4Jul 31, 2018
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Mar 31, 2019
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 29.50%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)3.85%
Return on Equity (ttm)9.02%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)8.00%
Gross Profit (ttm)800.73M
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.29
Quarterly Earnings Growth (yoy)198.60%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.64
Book Value Per Share (mrq)4.09

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A